Company page

Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc. (ticker: DYN) is a publicly traded company based in the United States, with a market capitalization of approximately $4.49 billion. The company focuses on developing innovative therapies for serious diseases, leveraging its proprietary technology platform. Dyne Therapeutics aims to address unmet medical needs through its research and development efforts.